Skip to main content
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 6, Number 8, 2006

Articles

Favourites:
ADD

Can we Target the Chemokine Network for Cancer Therapeutics?
pp. 659-670(12)
Authors: Giles, Ryan; Loberg, Robert D.

Favourites:
ADD

The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies
pp. 671-679(9)
Authors: Ferrajoli, A.; Faderl, S.; Ravandi, F.; Estrov, Z.

Favourites:
ADD

Modulation of the Cell Cycle and Induction of Apoptosis in Human Cancer Cells by Synthetic Bile Acids
pp. 681-689(9)
Authors: Deuk Kim, Nam; Im, Eunok; Hyun Yoo, Young; Hyun Choi, Yung

Favourites:
ADD

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
pp. 691-710(20)
Authors: Astsaturov, Igor; Cohen, Roger B.; Harari, Paul M.

Favourites:
ADD
Favourites:
ADD

Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes
pp. 729-751(23)
Authors: Dolle, Laurent; Depypere, Herman T.; Bracke, Marc E.

Favourites:
ADD

Free Content ERRATUM
pp. 753-753(1)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content